Clinical Trial Update: Artificial Intelligence in New Cardiac MR Markers for Congenital Heart Disease

View source ↗

Summary

An invitation-only clinical trial at Sahlgrenska University Hospital is evaluating AI-enhanced cardiac MRI markers for congenital heart disease, with focus on a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Congenital Heart Disease
• Pulmonary Valve Disease

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Aortic Valve Disease, Pulmonary Valve Disease | Status: ENROLLING_BY_INVITATION